ethidium has been researched along with palmitoylcarnitine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fonfria, E; Michel, AD | 1 |
Bonneau, D; Chao de la Barca, JM; Chevrollier, A; Chupin, S; Dalla Rosa, I; Desquiret-Dumas, V; Goudenege, D; Gueguen, N; Khiati, S; Le Mao, M; Lenaers, G; Logan, DC; Manero, F; Perrot, R; Procaccio, V; Reynier, P; Wakim, J | 1 |
2 other study(ies) available for ethidium and palmitoylcarnitine
Article | Year |
---|---|
Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Ethidium; Fluorometry; Humans; Interleukin-1beta; Lipids; Lysophosphatidylcholines; Mice; Octoxynol; Palmitoylcarnitine; Phosphorylcholine; Purinergic P2 Receptor Agonists; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X7; Sphingosine; Surface-Active Agents | 2007 |
CLUH couples mitochondrial distribution to the energetic and metabolic status.
Topics: Adenosine Triphosphate; Citric Acid Cycle; CRISPR-Cas Systems; DNA Damage; DNA, Mitochondrial; Ethidium; Gene Deletion; HeLa Cells; Humans; Metabolomics; Mitochondria; Mitochondrial Dynamics; Optical Imaging; Oxidation-Reduction; Oxidative Phosphorylation; Palmitoylcarnitine; Phosphatidylcholines; RNA-Binding Proteins | 2017 |